Subscribe To
Ride on rising p/e investing with these 5 top-ranked stocks
Want to try an out-of-the-box approach? Tap oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD)...
July 8, 2022, 9:20 am
oncolytics biotech, inc. (oncy) ceo matthew coffey on q1 2022 results - earnings call transcript
oncolytics Biotech, Inc. (NASDAQ:ONCY ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Corpora...
May 5, 2022, 9:55 pm
oncolytics biotech, inc. (oncy) ceo matthew coffey on q4 2021 results - earnings call transcript
oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call Transcript...
March 3, 2022, 10:39 pm
oncolytics biotech, inc. (oncy) ceo matthew coffey on q4 2021 results - earnings call transcript
oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call Transcript...
March 3, 2022, 10:39 pm
oncolytics biotech, inc. (oncy) ceo matthew coffey on q4 2021 results - earnings call transcript
oncolytics Biotech, Inc. (ONCY) CEO Matthew Coffey on Q4 2021 Results - Earnings Call Transcript...
March 3, 2022, 10:39 pm
Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...
January 30, 2022, 7:52 pm
Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...
January 30, 2022, 7:52 pm
Imugene secures japanese grant notice for oncolytic virotherapy cf33 patent
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received a notice of grant from the Japanese Patent Office for Patent Application number 2019-507161 which protec...
January 30, 2022, 7:52 pm
Imugene secures fda approval for two clinical trials of promising oncology drug candidates
Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology treatments...
December 12, 2021, 7:40 pm
Imugene secures fda approval for two clinical trials of promising oncology drug candidates
Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology treatments...
December 12, 2021, 7:40 pm
Imugene secures fda approval for two clinical trials of promising oncology drug candidates
Imugene Limited (ASX:IMU, OTC:IUGNF) has obtained US Food and Drug Administration (FDA) consent for clinical trials for two of its oncology treatments...
December 12, 2021, 7:40 pm